A.S. Herford.[J].Chin J Traumatol,2017,20(1):1-3. [doi]
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
  
DOI：
KeyWord: No Keywords.
FundProject:
Author NameAffiliation
A.S. Herford Department of Oral and Maxillofacial Surgery, Loma Linda University, Loma Linda, CA, USA 
Hits:
Download times:
Abstract:
      In recent years, recombinant human bone morphogenetic protein-2 (rhBMP-2) has been introduced as a therapeutic option in the treatment of several congenital and acquired craniofacial defects. Although there have been promising clinical results, the international literature still lacks complete guidelines, including limits and indications for the use of rhBMP-2. The possible indications for rhBMP-2 in patients undergoing facial trauma are discussed in this article.
View Full Text   View/Add Comment  Download reader
Close